Trump's Copper 'Aid': Sacrificing Health for Corporate Gain
According to The Telegraph, Donald Trump's new aid trade proposes exchanging life-saving HIV drugs for copper from resource-rich African nations. It's framed as a genius, market-driven solution to global health and mineral supply. Yet, this isn't innovation; it's a throwback to colonial-era resource extraction, thinly veiled in medical philanthropy. Countries struggling with public health crises
are now expected to mortgage their natural wealth for basic medicines, turning humanitarian aid into a transactional resource grab. One might generously call this a 'win-win,' but for whom? This 'solution' conveniently ignores decades of Western exploitation that left many of these nations economically vulnerable in the first place. Instead of addressing systemic issues, it entrenches a dependency
where essential public health is contingent on a nation's ability to provide raw materials to the Global North. It raises immediate questions: Who sets the copper price? Who decides the drug tariffs? And how many historical examples do we need to see before we recognize resource plundering when it’s dressed up in a MAGA hat?